Palantir Technologies shares fell 5% to $143, diverging from the broader tech rally as the NASDAQ 100 rose 3%. Despite impressive growth with Q4 2025 revenue up 70% year-over-year and net income surging 251.59%, the stock faces pressure due to an extremely high valuation (P/E ratio of 261x) and regulatory scrutiny in the UK related to its AI use in public health and defense. While analysts remain bullish with price targets well above current levels, investor skepticism persists, reflected in a 15.57% year-to-date decline. Key factors to watch include the resolution of UK regulatory issues and whether the stock stabilizes near its 50-day moving average or falls further.
The SPDR NYSE Technology ETF (XNTK) has significantly outperformed the Invesco QQQ Trust (QQQ) over the past year, returning 51.65% compared to QQQ's 28.43%. XNTK uses an equal-weight approach focusing solely on about 35 tech leaders, capturing broad...
YieldMax Ultra Option Income Strategy ETF (ULTY) promises a high annualized yield near 62% through weekly distributions by selling options on volatile tech stocks. However, its total return over the past year was -4.8%, far below the S&P 500's 22% ga...
Palantir reported an 85% increase in revenue while keeping operating expenses to a 32% rise, resulting in 60% adjusted operating margins and 57% free cash flow margins. The company's earnings and free cash flow are growing faster than sales due to st...
TappAlpha introduced the TappAlpha Cboe Magnificent 10 Growth & Daily Income ETF (TMGN), which offers exposure to the Cboe Magnificent 10 Index featuring leading tech companies like Nvidia, Microsoft, and Apple. This ETF applies TappAlpha's options-b...
Tech investor Chamath Palihapitiya warned that the rising costs of artificial intelligence (AI) usage might negatively impact some companies' earnings. He highlighted that many CEOs and CFOs are unaware of the extent of AI-related spending, which cou...
